功能性甲状腺毒症合并甲状腺风暴后饿骨综合征1例

C. Kaewkrasaesin, P. Srichomkwun
{"title":"功能性甲状腺毒症合并甲状腺风暴后饿骨综合征1例","authors":"C. Kaewkrasaesin, P. Srichomkwun","doi":"10.21037/aot-21-18","DOIUrl":null,"url":null,"abstract":"other etiologies of hypocalcemia after thyrotoxicosis treatment are rare. We aimed to report the first case of persistent hypocalcemia after thyrotoxicosis factitia treatment. Case Description: A 56-year-old woman presented a thyroid storm at the Emergency Department of a referral hospital in Bangkok, Thailand. Thyrotoxicosis factitia was diagnosed due to a low thyroglobulin (Tg) level together with a history of using levothyroxine as an over-the-counter weight loss pill. Systemic glucocorticoid, together with comprehensive end-organ supportive therapy, was administered to achieve euthyroidism. During admission, the serum calcium level gradually decreased to as low as 6.25 mg/dL, whereas serum intact parathyroid hormone and the alkaline phosphatase (ALP) level considerably increased. Intravenous calcium gluconate, oral calcium carbonate, and vitamin D were administered aggressively to treat severe hypocalcemia. Oral administration of calcium carbonate, ergocalciferol, and alphacalcidol was successfully reduced and discontinued two months after the patient was discharged from the hospital. Conclusions: The abrupt discontinuation of exogenous levothyroxine in the thyrotoxicosis factitia led to an acceleration of the skeletal calcium uptake and resulted in hypocalcemia. Therefore, the close monitoring of the calcium and bone mineral metabolism in patients diagnosed with thyrotoxicosis factitia receiving treatment is recommended.","PeriodicalId":92168,"journal":{"name":"Annals of thyroid","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2022-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Hungry bone syndrome after thyrotoxicosis factitia complicated with thyroid storm: a case report\",\"authors\":\"C. Kaewkrasaesin, P. Srichomkwun\",\"doi\":\"10.21037/aot-21-18\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"other etiologies of hypocalcemia after thyrotoxicosis treatment are rare. We aimed to report the first case of persistent hypocalcemia after thyrotoxicosis factitia treatment. Case Description: A 56-year-old woman presented a thyroid storm at the Emergency Department of a referral hospital in Bangkok, Thailand. Thyrotoxicosis factitia was diagnosed due to a low thyroglobulin (Tg) level together with a history of using levothyroxine as an over-the-counter weight loss pill. Systemic glucocorticoid, together with comprehensive end-organ supportive therapy, was administered to achieve euthyroidism. During admission, the serum calcium level gradually decreased to as low as 6.25 mg/dL, whereas serum intact parathyroid hormone and the alkaline phosphatase (ALP) level considerably increased. Intravenous calcium gluconate, oral calcium carbonate, and vitamin D were administered aggressively to treat severe hypocalcemia. Oral administration of calcium carbonate, ergocalciferol, and alphacalcidol was successfully reduced and discontinued two months after the patient was discharged from the hospital. Conclusions: The abrupt discontinuation of exogenous levothyroxine in the thyrotoxicosis factitia led to an acceleration of the skeletal calcium uptake and resulted in hypocalcemia. Therefore, the close monitoring of the calcium and bone mineral metabolism in patients diagnosed with thyrotoxicosis factitia receiving treatment is recommended.\",\"PeriodicalId\":92168,\"journal\":{\"name\":\"Annals of thyroid\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-02-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Annals of thyroid\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.21037/aot-21-18\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Annals of thyroid","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.21037/aot-21-18","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

甲状腺毒症治疗后低钙的其他病因是罕见的。我们的目的是报告首例在甲状腺毒症治疗后出现持续性低钙的病例。病例描述:一名56岁妇女在泰国曼谷一家转诊医院的急诊科出现甲状腺风暴。由于甲状腺球蛋白(Tg)水平低以及使用左甲状腺素作为非处方减肥药的历史,诊断为功能性甲状腺毒症。全身性糖皮质激素,结合全面的终末器官支持治疗,达到甲状腺功能亢进。入院时,血清钙水平逐渐下降至6.25 mg/dL,而血清完整甲状旁腺激素和碱性磷酸酶(ALP)水平明显升高。静脉注射葡萄糖酸钙、口服碳酸钙和维生素D积极治疗严重低钙血症。口服碳酸钙、麦角钙化醇和甲骨化醇成功减少,并在患者出院两个月后停用。结论:假性甲状腺毒症患者突然停用外源性左旋甲状腺素导致骨骼钙摄取加速,导致低钙血症。因此,建议在诊断为甲亢的患者接受治疗时密切监测钙和骨矿物质代谢。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Hungry bone syndrome after thyrotoxicosis factitia complicated with thyroid storm: a case report
other etiologies of hypocalcemia after thyrotoxicosis treatment are rare. We aimed to report the first case of persistent hypocalcemia after thyrotoxicosis factitia treatment. Case Description: A 56-year-old woman presented a thyroid storm at the Emergency Department of a referral hospital in Bangkok, Thailand. Thyrotoxicosis factitia was diagnosed due to a low thyroglobulin (Tg) level together with a history of using levothyroxine as an over-the-counter weight loss pill. Systemic glucocorticoid, together with comprehensive end-organ supportive therapy, was administered to achieve euthyroidism. During admission, the serum calcium level gradually decreased to as low as 6.25 mg/dL, whereas serum intact parathyroid hormone and the alkaline phosphatase (ALP) level considerably increased. Intravenous calcium gluconate, oral calcium carbonate, and vitamin D were administered aggressively to treat severe hypocalcemia. Oral administration of calcium carbonate, ergocalciferol, and alphacalcidol was successfully reduced and discontinued two months after the patient was discharged from the hospital. Conclusions: The abrupt discontinuation of exogenous levothyroxine in the thyrotoxicosis factitia led to an acceleration of the skeletal calcium uptake and resulted in hypocalcemia. Therefore, the close monitoring of the calcium and bone mineral metabolism in patients diagnosed with thyrotoxicosis factitia receiving treatment is recommended.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
0.90
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信